AMR-109

N/A

Report date: 2025/07/25 20:00:41
NME

Base Information

Drug NameAMR-109
Drug Alias Nameomega-3 fatty acids (Amarin)AMR-109
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmarin Corporation Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmarin Corporation Plc
Active IndicationsN/A
Inactive IndicationsCognition Disorders

Other Information

ATC CodeN/A
Related LinksN/A